🎥 New Covid-19 Vaccine - NOVAVAX - A Traditional Style Vaccine (EVERYTHING YOU NEED TO KNOW)

Novavax is a company that produced a new type of COVID-19 vaccine. Essentially, their product is a traditional style, protein based vaccine, similar to the flu shot (influenza). This jab contains parts of the spike protein, and an adjuvant called Matrix-M. As a result, it works differently in the body compared to most of the current COVID-19 vaccine offerings. This company is planning to receive approval by the FDA for emergency use in the United States as early as December 2021. In this video I will explain EVERYTHING YOU NEED TO KNOW ABOUT NOVAVAX. That way, you can decide if this vaccine is right for you. Please see KEY POINTS below for more details. WATCH VIDEO BY CLICKING ABOVE 👆🏻

KEY POINTS:

1.) Novavax specializes in vaccine developmental and research regarding viral pathogens

2.) Novavax (NVX-CoV2373) is a subunit protein vaccine

3.) Novavax DOES NOT CONTAIN mRNA

4.) Novavax DOES NOT CONTAIN DNA

5.) Novavax is NOT A VIRAL VECTOR VACCINE

6.) Novavax is NOT A LIVE/ATTENUATED VIRUS VACCINE

7.) Novavax plans to receive FDA approval for emergency use in the USA as early as DECEMBER 2021

8.) This vaccine is given is 2 DOSES 21 DAYS APART

9.) PREVENT-19 clinical trial revealed VACCINE EFFECTIVENESS OF 90.4%

10.) Prevent-19 clinical trial was randomised, observer-blinded, placebo, controlled - GOLD STANDARD

11.) Prevent-19 trial involved nearly 30,000 individuals at least 18 years or older from USA and MEXICO

12.) Vaccination was in a 2:1 ratio. Meaning, 19,714 received the jab, and 9868 received placebo

13.) Efficacy was measured against COVID-19 RT-PCR TEST - So, only 14 individuals in the vaccine group ended up contracting COVID-19. On the other hand, 66 individuals in the placebo contracted COVID-19

14.) Testing was done early as 7 day after 2nd dose

RESEARCH:

https://www.medrxiv.org/content/10.1101/2021.10.05.21264567v1

https://jamescintolo.substack.com/p/vaccine-cheat-sheet-moderna-pfizer

https://ir.novavax.com/2021-06-30-Novavax-Publishes-Results-of-United-Kingdom-Phase-3-Clinical-Trial-in-New-England-Journal-of-Medicine,-Demonstrating-High-Levels-of-Efficacy-of-COVID-19-Vaccine

https://www.nejm.org/doi/full/10.1056/NEJMoa2107659?query=featured_home

---

LET'S CONNECT:

https://www.facebook.com/james.cintolo

https://www.facebook.com/healthbyjames

https://jamescintolo.substack.com

https://www.patreon.com/jamescintolo

https://www.buymeacoffee.com/healthbyjames

https://www.instagram.com/healthbyjamesc